- ￥4385
- abcam
- AB141197
- 2025年08月03日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
5-Fluorocytosine (5-FC)
- 抗体英文名：
5-Fluorocytosine (5-FC)
- 克隆性：
多克隆
- 规格：
5g
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Clinical Trials With GDEPT: Cytosine Deaminase and 5-Fluorocytosine
of converting the nontoxic prodrug 5-fluorocytosine (5-FC) to 5-fluorouracil (5-FU), which inhibits RNA and DNA synthesis during the S-phase of the cell cycle (1 ). This system has been used both in vitro and in preclinical studies showing antitumor activity
Intratumoral Gene Transfer of the Cytosine Deaminase Gene for the Treatment of Breast Cancer
the nontoxic prodrug 5-fluorocytosine (5-FC) to the toxic metabolite 5-fluorouracil (5-FU), which inhibits RNA and DNA synthesis during S-phase of the cell cycle (1 ,2 ). We have devised a transcriptionally targeted GPAT strategy in which expression of CD
药物靶向治疗（drugs targeting）机理可概括为病毒导向酶的药物前体治疗（virus directed enzyeme prodrug therapy,VDEPT），即用反转录病毒载体的外源基因转移到细胞内.该基因编码一种酶，此酶可将一种无害的药物前体转变为细胞毒素复合物。带有这一基因的病毒载体只在特殊组织或肿瘤细胞中而不在正常细胞中表达。例如，胞嘧啶脱氨酶（cytosine deaminase）可将无害的5－氟胞嘧啶（5-fluorocytosine,5-FC）转变为细胞
技术资料暂无技术资料 索取技术资料
